These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26824357)

  • 1. Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives.
    Gloux K; Anba-Mondoloni J
    PLoS One; 2016; 11(1):e0148291. PubMed ID: 26824357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae.
    Little MS; Pellock SJ; Walton WG; Tripathy A; Redinbo MR
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E152-E161. PubMed ID: 29269393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
    Khanna S; Raffals LE
    Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A metagenomic β-glucuronidase uncovers a core adaptive function of the human intestinal microbiome.
    Gloux K; Berteau O; El Oumami H; Béguet F; Leclerc M; Doré J
    Proc Natl Acad Sci U S A; 2011 Mar; 108 Suppl 1(Suppl 1):4539-46. PubMed ID: 20615998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbial beta-glucuronidase and glycerol/diol dehydratase activity contribute to dietary heterocyclic amine biotransformation.
    Zhang J; Lacroix C; Wortmann E; Ruscheweyh HJ; Sunagawa S; Sturla SJ; Schwab C
    BMC Microbiol; 2019 May; 19(1):99. PubMed ID: 31096909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.
    Liguori G; Lamas B; Richard ML; Brandi G; da Costa G; Hoffmann TW; Di Simone MP; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    J Crohns Colitis; 2016 Mar; 10(3):296-305. PubMed ID: 26574491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity of Escherichia coli in gut microbiota of patients with Crohn's disease discovered using metagenomic and genomic analyses.
    Tyakht AV; Manolov AI; Kanygina AV; Ischenko DS; Kovarsky BA; Popenko AS; Pavlenko AV; Elizarova AV; Rakitina DV; Baikova JP; Ladygina VG; Kostryukova ES; Karpova IY; Semashko TA; Larin AK; Grigoryeva TV; Sinyagina MN; Malanin SY; Shcherbakov PL; Kharitonova AY; Khalif IL; Shapina MV; Maev IV; Andreev DN; Belousova EA; Buzunova YM; Alexeev DG; Govorun VM
    BMC Genomics; 2018 Dec; 19(1):968. PubMed ID: 30587114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysbiotic gut microbiome: A key element of Crohn's disease.
    Øyri SF; Műzes G; Sipos F
    Comp Immunol Microbiol Infect Dis; 2015 Dec; 43():36-49. PubMed ID: 26616659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysbiosis in a canine model of human fistulizing Crohn's disease.
    Maldonado-Contreras A; Ferrer L; Cawley C; Crain S; Bhattarai S; Toscano J; Ward DV; Hoffman A
    Gut Microbes; 2020 Nov; 12(1):1785246. PubMed ID: 32730134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut dysbiosis in Crohn's disease: Never so close to solving the chicken-and-egg enigma: Commentary to "Gut microbiome composition is associated with future onset of Crohn's disease in healthy first-degree relatives, by Raygoza Garay JA et al., Gastroenterology 2023".
    Grellier N; Sokol H; Seksik P
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102272. PubMed ID: 38145785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for bacterial urease in gut dysbiosis and Crohn's disease.
    Ni J; Shen TD; Chen EZ; Bittinger K; Bailey A; Roggiani M; Sirota-Madi A; Friedman ES; Chau L; Lin A; Nissim I; Scott J; Lauder A; Hoffmann C; Rivas G; Albenberg L; Baldassano RN; Braun J; Xavier RJ; Clish CB; Yudkoff M; Li H; Goulian M; Bushman FD; Lewis JD; Wu GD
    Sci Transl Med; 2017 Nov; 9(416):. PubMed ID: 29141885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Atlas of β-Glucuronidases in the Human Intestinal Microbiome.
    Pollet RM; D'Agostino EH; Walton WG; Xu Y; Little MS; Biernat KA; Pellock SJ; Patterson LM; Creekmore BC; Isenberg HN; Bahethi RR; Bhatt AP; Liu J; Gharaibeh RZ; Redinbo MR
    Structure; 2017 Jul; 25(7):967-977.e5. PubMed ID: 28578872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.
    Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K
    Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amoxapine Demonstrates Incomplete Inhibition of β-Glucuronidase Activity from Human Gut Microbiota.
    Yang W; Wei B; Yan R
    SLAS Discov; 2018 Jan; 23(1):76-83. PubMed ID: 28809607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
    Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
    Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease.
    Tronstad RR; Kummen M; Holm K; von Volkmann HL; Anmarkrud JA; Høivik ML; Moum B; Gilja OH; Hausken T; Baines J; Karlsen TH; Fiskerstrand T; Hov JR
    Inflamm Bowel Dis; 2017 Oct; 23(10):1752-1761. PubMed ID: 28902124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysbiotic microbiota interactions in Crohn's disease.
    Caparrós E; Wiest R; Scharl M; Rogler G; Gutiérrez Casbas A; Yilmaz B; Wawrzyniak M; Francés R
    Gut Microbes; 2021; 13(1):1949096. PubMed ID: 34313550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.